|
|
News Breaks | | | | November 12, 2012 | | 07:28 EDT |  | SQNM | Sequenom upgraded to Buy from Hold at Jefferies
Jefferies upgraded Sequenom after its proprietary survey indicated the company is experiencing meaningful traction obtaining reimbursement coverage for its T21 laboratory developed test. The firm keeps a $7 price target for shares. | |
|
News For SQNM From The Last 14 Days Check below for free stories on SQNM the last two weeks. |
|
|
| May 13, 2013 | | 10:09 EDT | | SQNM | On The Fly: Analyst Upgrade Summary
 Subscribe for More Information | | | 06:28 EDT | | SQNM | Sequenom upgraded to Neutral from Underperform at Credit Suisse
Subscribe for More Information | | | May 10, 2013 | | 12:31 EDT |  | SQNM | On The Fly: Midday Wrap
Subscribe for More Information | | | May 9, 2013 | | 18:52 EDT |  | SQNM | On The Fly: After Hours Movers
UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. | | | 16:24 EDT |  | SQNM | Sequenom reports Q1 EPS (26c), consensus (24c)
Subscribe for More Information | | | May 7, 2013 | | 10:06 EDT |  | SQNM | Sequenom shares recommended at Maxim
Subscribe for More Information | |
|
|
|
|
|
|
